Rheumatoid polyneuropathy with seropositive (rheumatoid factor–positive) rheumatoid arthritis affecting multiple joint sites simultaneously.
Verified May 8, 2026 · 5 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 5
- Region
- Multi-region
Documentation tips
What should appear in the chart to support M05.59.
Source · Editorial brief grounded in 5 cited references ↓
- Document positive rheumatoid factor (RF) or anti-CCP lab result explicitly — M05 codes require seropositive status and payers may deny without lab evidence in the record.
- Name each affected joint site or use language such as 'polyarticular involvement' to support the 'multiple sites' designation and justify M05.59 over a site-specific M05.5x code.
- Record the neurological findings — numbness, tingling, weakness, sensory loss, abnormal EMG/NCS — that substantiate the polyneuropathy component as a systemic RA manifestation.
- Note current disease-modifying or biologic therapy (e.g., methotrexate, TNF inhibitor) in the assessment; this supports medical necessity for ongoing management and risk-adjustment coding.
- If imaging or joint aspiration supports active synovitis at multiple sites, include those findings to reinforce polyarticular disease documentation.
Related CPT procedures
Procedure codes commonly billed with M05.59. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M05.59 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Using M05.59 when only one joint site is involved — if a single site dominates, use the corresponding laterality-specific M05.5x code (e.g., M05.561 for right knee) instead.
- Assigning M05.59 without documented seropositivity — if RF and anti-CCP are negative or not tested, M06 codes are appropriate; M05 requires confirmed rheumatoid factor positivity.
- Adding a separate peripheral neuropathy code (e.g., G62.9) when the polyneuropathy is explicitly documented as a rheumatoid manifestation — the complication is already captured in M05.59.
- Confusing M05.59 (polyneuropathy, multiple sites) with M05.79 (rheumatoid arthritis with rheumatoid factor, multiple sites, without organ/system involvement) — M05.59 requires the neurological complication to be documented.
- Defaulting to M05.9 (unspecified) when the record clearly documents neuropathy and polyarticular disease — that level of specificity makes M05.59 the correct and more complete code.
Clinical context
Source · Editorial summary grounded in 5 cited references ↓
M05.59 applies when a patient with confirmed rheumatoid factor–positive rheumatoid arthritis develops peripheral polyneuropathy as a recognized systemic complication, and the joint involvement spans multiple sites (e.g., bilateral hands, wrists, knees, or feet together). The '9' sixth character signals multiple sites rather than a single named joint — use this code only when the clinical record documents polyarticular disease, not a single isolated joint with neuropathic changes.
Within the M05.5x family, site-specific codes exist for shoulder (M05.51x), elbow (M05.52x), wrist (M05.53x), hand (M05.54x), hip (M05.55x), knee (M05.56x), and ankle/foot (M05.57x), each with right (1), left (2), and unspecified (9) laterality options. M05.59 is the correct choice only when the provider explicitly documents involvement at multiple sites or the disease is polyarticular and no single dominant site is specified.
Because M05.59 sits under M05 (Rheumatoid arthritis with rheumatoid factor), seropositivity must be reflected in the record — a positive RF or anti-CCP lab result documented by the treating clinician. If seropositivity is not established, consider M06 codes for seronegative or other rheumatoid arthritis. The neuropathy here is the rheumatoid polyneuropathy that is a systemic manifestation of the RA itself, not a separate peripheral neuropathy from another etiology; do not stack an additional neuropathy code unless a distinct, separately documented neuropathic etiology exists.
Sibling codes
Other billable codes under M05.5 (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 5 cited references ↓
01Does M05.59 require a positive rheumatoid factor lab result?
02When should I use M05.59 instead of a site-specific M05.5x code?
03Should I code the polyneuropathy separately with a G-code?
04What is the difference between M05.59 and M05.79?
05Can M05.59 be used as a primary diagnosis for an orthopedic encounter?
06Is M05.59 appropriate when only bilateral hands and wrists are involved?
07Does M05.59 have 7th-character extension requirements?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026 (effective Oct 1, 2025)
- 02icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M05-M14/M05-/M05.59
- 03aapc.comhttps://www.aapc.com/codes/icd-10-codes/M05.59
- 04rhinomds.comhttps://rhinomds.com/m05-icd-10-codes-for-rheumatoid-arthritis-2026-a-billing-coding-guide/
- 05health.ny.govhttps://www.health.ny.gov/diseases/conditions/arthritis/provider_toolkit/attachment_1.pdf
Mira AI Scribe
Mira AI Scribe captures the RF/anti-CCP lab positivity, the named joint sites involved (bilateral or multiple), and the specific neurological symptoms (e.g., distal sensory loss, paresthesias) or EMG/NCS findings that confirm polyneuropathy as a systemic RA complication. That documentation prevents the claim from being downcoded to unspecified M05.9 or denied for missing evidence of both the neuropathic manifestation and polyarticular involvement.
See how Mira captures M05.59 documentation